TLOG (TetraLogic Pharmaceuticals) YoY EPS Growth: 23.91% (As of Sep. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is TetraLogic Pharmaceuticals YoY EPS Growth?

TetraLogic Pharmaceuticals TLOG +150.00% YoY EPS Growth is 23.91% as of Sep. 2016.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. TetraLogic Pharmaceuticals's YoY EPS Growth for the quarter that ended in Sep. 2016 was 23.91%.

TetraLogic Pharmaceuticals's Earnings per Share (Diluted) for the three months ended in Sep. 2016 was $-0.35.

TetraLogic Pharmaceuticals YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals YoY EPS Growth Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
YoY EPS Growth
0.00 -16.73 50.10 83.88 -28.83

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.52 -9.43 19.64 47.06 23.91

TetraLogic Pharmaceuticals YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

TetraLogic Pharmaceuticals's YoY EPS Growth for the fiscal year that ended in Dec. 2015 is calculated as:

YoY EPS Growth (A: Dec. 2015 )
=(Earnings per Share (Diluted) (A: Dec. 2015 )-Earnings per Share (Diluted) (A: Dec. 2014 ))/ | Earnings per Share (Diluted) (A: Dec. 2014 ) |
=(-2.1--1.63)/ | -1.63 |
=-28.83 %

TetraLogic Pharmaceuticals's YoY EPS Growth for the quarter that ended in Sep. 2016 is calculated as:

YoY EPS Growth (Q: Sep. 2016 )
=(Earnings per Share (Diluted) (Q: Sep. 2016 )-Earnings per Share (Diluted) (Q: Sep. 2015 )) / | Earnings per Share (Diluted) (Q: Sep. 2015 )) |
=(-0.35--0.46)/ | -0.46 |
=23.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 23.91% mean?
TetraLogic Pharmaceuticals (TLOG) has a YoY EPS Growth of 23.91% as of Sep. 2016. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' YoY EPS Growth too high?
TetraLogic Pharmaceuticals' current YoY EPS Growth is 23.91%.
How does TetraLogic Pharmaceuticals' YoY EPS Growth compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' YoY EPS Growth of 23.91% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Biotechnology company?
A good YoY EPS Growth depends on the Biotechnology industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current YoY EPS Growth is 23.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current YoY EPS Growth of 23.91%. The current YoY EPS Growth is 23.91%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current YoY EPS Growth is 23.91% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.